2025 Approvals & Highlights
1 h 49 min
Martin Reck
LungenClinic Grosshansdorf
Prof. Martin Reck heads the Department of Thoracic Oncology at LungenClinic Grosshansdorf in Germany. He has led pivotal first-line immunotherapy trials in metastatic NSCLC, including KEYNOTE-024, and continues to drive evidence generation across the lung cancer treatment landscape. He is a frequent speaker at major international congresses.
Connect
Martin Reck
Featured in
Dec
18
2025
Sep
20
2024
OncoNews
Bridging The Gap In Thoracic Oncology: What To Expect From The 6th ILCS
[et_pb_section fb_built ="1" admin_label ="section" _builder_version ="4.27.4" background_color ="#f5f8fb" positioning ="none" z_index ="0" custom_padding ="0px||0px|||" global_colors_info ="{}" theme_builder_area ="post_content"][et_pb_row admin_label ="row" _builder_version ="4.27.4" background_size ="initial" background_position ="top_left" background_repeat ="repeat" width...
